The role of fractional exhaled nitric oxide in the assessment of athletes reporting exertional dyspnoea

Allen, Hayden, Hull, James H., Backhouse, Susan H., Dickinson, John W., De Carné, Taidgh, Dimitriou, Lygeri ORCID: https://orcid.org/0000-0002-5093-558X and Price, O. (2019) The role of fractional exhaled nitric oxide in the assessment of athletes reporting exertional dyspnoea. Allergy, Volume 74, Issue S106 Special Issue:Abstracts from the European Academy of Allergy and Clinical Immunology Congress, 01–05 June 2019, Lisbon, Portugal. In: European Academy of Allergy and Clinical Immunology Congress, 01-05 Jun 2019, Lisbon, Portugal. . ISSN 0105-4538 [Conference or Workshop Item] (doi:10.1111/all.13959)

PDF (Abstract-Poster Presentation) - Final accepted version (with author's formatting) Download (266kB)

Abstract

Background: Exercise-induced bronchoconstriction (EIB) is a common cause of breathing difficulty in athletes. Fractional exhaled nitric oxide (FeNO) is an indirect marker of airway inflammation, recommended for the assessment and management of asthma; however, the role of FeNO in detecting and monitoring EIB has yet to be fully established. The aim of this study was therefore to evaluate the predictive value of FeNO to confirm or refute EIB in athletes presenting with exertional dyspnoea.

Method: Seventy athletes (male: n = 45) (age: 35 ± 11 years) reporting respiratory symptoms (i.e. wheeze, cough and dyspnoea) during exercise attended the laboratory on a single occasion. All athletes performed resting FeNO and spirometry pre-and-post a eucapnic voluntary hyperpnoea challenge (EVH) in accordance with international guidelines. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were calculated for established FeNO thresholds: (intermediate [≥25ppb] and high [>50ppb]) and evaluated against objective evidence of EIB: (EVH diagnostic cut-off [-10% ΔFEV1 at two consecutive time-points] and [-15% ΔFEV1 at one time-point]). The diagnostic accuracy of FeNO was calculated using receiver operating characteristics area under the curve (ROC-AUC).

Results: All had normal resting lung function (>80% FEV1 pred). The prevalence of EIB was 33% (-10% ΔFEV1) and 23% (-15% ΔFEV1) (median (IQR) ΔFEV1 = -7% (10.02)). FeNO values ≥25ppb and >50ppb were observed in 49% and 23% of the cohort, respectively. ROC-AUC for FeNO was 75% (-10% ΔFEV1) and 86% (-15% ΔFEV1). Sensitivity, specificity, PPV and NPV are presented in Table 1.

Conclusion: Our findings indicate that FeNO >50ppb provides good specificity for a positive EVH test; however, should not replace indirect bronchoprovocation for diagnostic purposes. The high proportion of athletes reporting breathing difficulty in the absence of EIB highlights the requirement to consider alternative causes of exertional dyspnoea during clinical work-up.

Actions (login required)

View Item

Statistics

DownloadsShow export options

Export as CSVXMLJSON

Activity Overview

6 month trend

67Downloads

6 month trend

202Hits

Additional statistics are available via IRStats2.